AWK:NYSEAmerican Water Works Company, Inc. Analysis
Data as of 2026-08-02 - not real-time
$134.17
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
American Water Works (AWK) trades in a neutral technical zone with the 20‑day SMA just above the 50‑day SMA and a modest bullish MACD histogram, while price hovers near a key support level. Fundamentally, the company delivers solid earnings per share growth and a dividend yield that remains attractive for income‑focused investors, though the price‑to‑earnings multiple sits above the sector average, indicating a premium valuation. The DCF model points to a valuation gap, suggesting the market price incorporates optimistic expectations. Operating cash flow comfortably covers the dividend, but free cash flow remains negative, highlighting the capital‑intensive nature of regulated water infrastructure. Volatility over the past month is elevated, yet beta is negative, implying the stock may move opposite to broader market swings, which can be a defensive trait in turbulent environments. Upcoming quarterly results and a recently announced dividend increase add short‑term catalysts, while long‑term regulated rate hikes support earnings growth prospects.
Overall, AWK offers a blend of defensive stability and modest growth, but the current premium price tempers enthusiasm. Investors should weigh the strong dividend record and regulated revenue base against the valuation premium and cash‑flow constraints when deciding on exposure.
Overall, AWK offers a blend of defensive stability and modest growth, but the current premium price tempers enthusiasm. Investors should weigh the strong dividend record and regulated revenue base against the valuation premium and cash‑flow constraints when deciding on exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical stance with a bullish MACD signal
- Upcoming earnings release could clarify valuation
- Dividend increase reinforces income appeal
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable regulated revenue and modest earnings growth
- Attractive dividend yield with solid payout coverage
- Valuation premium remains a headwind
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Defensive utility exposure with low beta
- Long‑term rate‑increase potential supports earnings
- Consistent dividend growth history
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin21.35%
P/E Ratio23.3
ROE10.10%
ROA3.52%
Debt/Equity137.75
P/B Ratio2.3
Op. Cash Flow$2.3B
Free Cash Flow$-1785374976
Industry P/E20.5
Technical Analysis
TrendNeutral
RSI52.9
Support$128.95
Resistance$141.25
MA 20$133.63
MA 50$129.20
MA 200$131.33
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Fair Value$57.53
Target Price$140.27
Upside/Downside4.55%
GradeOvervalued
TypeValue
Dividend Yield2.67%
Risk Assessment
Beta-0.44
Volatility25.98%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.